C. Betriu et al., In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains, ANTIM AG CH, 45(8), 2001, pp. 2372-2374
The activity of MK-0826, a new carbapenem, against 309 Bacteroides fragilis
group strains was investigated and compared with that of 11 other beta -la
ctam and 5 non-beta -lactam agents. MK-0826 showed excellent activity (MICs
ranged from less than or equal to0.06 to 4 mug/ml). The new carbapenem may
be useful in the treatment of mixed anaerobic infections involving B. frag
ilis group strains.